Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Melanoma × Melatonin × Clear all

Sponsor

Conditions

Parasomnias 3 Breast Neoplasms 3 Weight Loss 2 Sleep Wake Disorders 2 Lung Neoplasms 2 Cachexia 2 Tuberous Sclerosis 1 Squamous Cell Carcinoma of Head and Neck 1 Smith-Magenis Syndrome 1 Quality of Life 1 Neoplasms 1 Hematologic Neoplasms 1 Gastrointestinal Neoplasms 1 Fatigue 1 Depression 1 Carcinoma, Non-Small-Cell Lung 1 Breast Cancer - Female 1 Autism Spectrum Disorder 1 Anxiety Disorders 1 Anorexia 1 Angelman Syndrome 1

Interventions

Ipilimumab 96 pembrolizumab 81 Nivolumab 79 aldesleukin 51 Cyclophosphamide 49 Interleukin-2 38 fludarabine phosphate 31 Vemurafenib 31 Dacarbazine 31 dabrafenib 29 trametinib 28 Temozolomide 26 fludarabine 25 CTLA-4 Antigen 18 Bevacizumab 18 Radiosurgery 15 Paclitaxel 15 Carboplatin 14 encorafenib 13 binimetinib 13 Introns 13 talimogene laherparepvec 12 Interferon alpha-2 12 spartalizumab 10 cobimetinib 10 atezolizumab 10 Radiotherapy 10 sargramostim 9 peginterferon alfa-2b 9 montanide ISA 51 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡